Q2 2021 Aptose Biosciences Inc Earnings Call Transcript
Good afternoon. My name is Mary and I will be your conference operator today. I would like to welcome everyone to Aptose Biosciences conference call for second quarter ended June 30, 2021. (Operator Instructions) Thank you. As a reminder, this conference call may be recorded.
I would like to introduce Ms. Susan Pietropaolo. Please go ahead.
Thank you, Mary. Good afternoon and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the first quarter ended June 30, 2021. Joining me on today's call are Dr. William G. Rice, Chairman, President and CEO; Dr. Jotin Marango, Senior Vice President, Chief Financial Officer and Chief Business Officer; and Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer.
Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the meaning of U.S. and Canadian securities laws. Forward-looking statements reflect Aptose's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |